期刊文献+

乳腺癌中p^(53)基因的表达及与雌激素受体的关系

Relationship between expression of p^(53) gene and estrogen receptor in human breast carcinoma
下载PDF
导出
摘要 目的 研究乳腺癌中 p53 基因的表达对乳腺癌生物学行为影响的意义。方法 应用S -P免疫组织化学方法对 5 4例乳腺癌石蜡包埋组织进行检测 ,研究乳腺癌组织中p53 基因的表达率、表达特点与临床病理和雌激素受体 (ER)的关系。结果 在人的乳腺癌中 p53 蛋白阳性染色主要位于细胞核中 ,阳性表达率为 5 5 .6 % ;ER阳性表达率为 46 .3% ;p53 基因阳性表达与乳腺癌组织学分级呈正相关 (P <0 .0 5 ) ;与临床病理分期无关 (P >0 .0 5 ) ;与淋巴结是否发生转移呈正相关 (P <0 .0 5 ) ;与ER受体表达呈负相关 (P <0 .0 5 )。结论 p53 基因突变参与了乳腺癌的发生和发展 ;p53 蛋白抑制了乳腺癌ER的分化。 Objective To study the affect of the expression of p 53 gene on the biological behavior of human breast cancer and the relationship between expression of p 53 protein and estrogen receptor(ER). Methods Using S-P immunohistochemical method,the expression of p 53 in 54 breast cancer tissue specimens fixed paraffin were detected. Meanwhile,the correlation of the expression rate and expression features of p 53 gene to the clinico-pathology and ER were observed.Results The majority of p 53 protein in human breast tumor tissue were located in cell nuclei and the positive rate was 55.6%.The expression rate of ER was 46.3%.Statistic analysis suggested that the positive expression of p 53 gene correlated with histological grade and metastasis (P<0.05),but did not relation with pathological stage (P>0.05).Positive expression of p 53 was negatively correlatiion with ER(P<0.05).Conclusion p 53 gene mutation involved in oncogenesis and development of breast cancer and it might inhibit the ER expression in breast carcinoma.
出处 《新乡医学院学报》 CAS 2001年第6期386-388,共3页 Journal of Xinxiang Medical University
关键词 乳腺癌 P^53基因 基因突变 雌激素受体 breast cancer p 53 gene gene mutation estrogen receptor
  • 相关文献

参考文献9

  • 1Zhang GJ,Kimijima I,Abe R,et al.Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers[].Anticancer Research.1998
  • 2Gretarsdottir S,Tryggvadottir L,Jonasson JG,et al.TP53 mutation analyses on breast earcinomas: a study of paraffin embedded archival material[].British Journal of Cancer.1996
  • 3Jaiyesimi IA.Inflammatory breast cancer: A review[].Journal of Clinical Oncology.1992
  • 4Tsuda H,Hirohashi S.Association among p53 gene mutation nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer[].International Journal of Cancer.1994
  • 5Nishmura R,Nagao K,Miyayama H,et al.Apoptotic in breast cancer and its relationship to clinicopathological characteristics and prognosis[].Journal of Surgical Oncology.1999
  • 6Deng G,chen LC,Schott DR,et al.Loss of heterozygosity and p53 gene mutations in breast cancer[].Cancer Research.1994
  • 7Kamel D,Puakko P,Nuorva K,et al.p53 and cerbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gallbladder[].Journal of Paleopathology.1993
  • 8Miyashita T,Reed JC.Tumor suppressor gene p53 is a direct transcriptional activator of the human Bax gene[].Cell.1995
  • 9Alanko AE,Heinonen E,Scheinin TM,et al.Significance of estrogen and progesterone receptors: disease-free interval and site of first metastasis on survival of breast cancer patients[].Cancer.1985

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部